Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry

BACKGROUND AND PURPOSE—There is controversy on the relationship of the type of atrial fibrillation (AF) to stroke. Although several studies show that patients with paroxysmal AF (PAF) have a stroke risk similar to those with persistent or permanent AF, recent studies suggest that PAF is associated w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke (1970) 2015-12, Vol.46 (12), p.3354-3361
Hauptverfasser: Takabayashi, Kensuke, Hamatani, Yasuhiro, Yamashita, Yugo, Takagi, Daisuke, Unoki, Takashi, Ishii, Mitsuru, Iguchi, Moritake, Masunaga, Nobutoyo, Ogawa, Hisashi, Esato, Masahiro, Chun, Yeong-Hwa, Tsuji, Hikari, Wada, Hiromichi, Hasegawa, Koji, Abe, Mitsuru, Lip, Gregory Y.H, Akao, Masaharu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND AND PURPOSE—There is controversy on the relationship of the type of atrial fibrillation (AF) to stroke. Although several studies show that patients with paroxysmal AF (PAF) have a stroke risk similar to those with persistent or permanent AF, recent studies suggest that PAF is associated with a lower rate of stroke. Limited data on stroke risk associated with PAF are evident in Asian populations. METHODS—The Registry Study of Atrial Fibrillation Patients in Fushimi-ku (Fushimi AF Registry) is a community-based survey of patients with AF in Fushimi-ku, Kyoto, Japan. Patients were categorized into 2 types of AFPAF or sustained (persistent or permanent) AF. We compared clinical events between PAF (n=1588) and sustained AF (n=1716). RESULTS—Patients with PAF were younger, had less comorbidities, and received oral anticoagulants (OAC) less commonly. A lower risk of stroke/systemic embolism during follow-up period in the patients with PAF was consistently observed (non-OAC usershazard ratio, 0.45; 95% confidence intervals, 0.27–0.75; P
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.115.010947